Search Results - "SCURI, Mario"

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial by Vestbo, Jørgen, Prof, Papi, Alberto, Prof, Corradi, Massimo, Prof, Blazhko, Viktor, MD, Montagna, Isabella, MSc, Francisco, Catherine, MSc, Cohuet, Géraldine, MSc, Vezzoli, Stefano, MSc, Scuri, Mario, MD, Singh, Dave, Prof

“…Summary Background Limited data are available for the efficacy of triple therapy with two long-acting bronchodilators and an inhaled corticosteroid in chronic…”
Get full text

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2 -agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial by Singh, Dave, Prof, Papi, Alberto, Prof, Corradi, Massimo, Prof, Pavlišová, Ilona, MD, Montagna, Isabella, MSc, Francisco, Catherine, MSc, Cohuet, Géraldine, MSc, Vezzoli, Stefano, MSc, Scuri, Mario, MD, Vestbo, Jørgen, Prof

“…Summary Background Few data are available for the efficacy of “triple therapy” with two long-acting bronchodilators and an inhaled corticosteroid in chronic…”
Get full text

Inhaled corticosteroid containing combinations and mortality in COPD by Vestbo, Jørgen, Fabbri, Leonardo, Papi, Alberto, Petruzzelli, Stefano, Scuri, Mario, Guasconi, Alessandro, Vezzoli, Stefano, Singh, Dave

Get full text

Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD by Chetta, Alfredo, Yorgancioglu, Arzu, Scuri, Mario, Barile, Sara, Guastalla, Daniele, Dekhuijzen, P N Richard

“…Inhaler selection is important when managing respiratory conditions; a patient's inhalation technique should be appropriate for the selected device, and…”
Get full text

The Lactoperoxidase System Functions in Bacterial Clearance of Airways by Gerson, Cynthia, Sabater, Juan, Scuri, Mario, Torbati, Aliza, Coffey, Richard, Abraham, Jeffrey W, Lauredo, Isabel, Forteza, Rosanna, Wanner, Adam, Salathe, Matthias, Abraham, William M, Conner, Gregory E

“…Airway mucus is a complex mixture of secretory products that provides a multifaceted defense against pulmonary infection. Mucus contains antimicrobial peptides…”
Get full text

Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial by Papi, Alberto, Vestbo, Jørgen, Fabbri, Leonardo, Corradi, Massimo, Prunier, Hélène, Cohuet, Géraldine, Guasconi, Alessandro, Montagna, Isabella, Vezzoli, Stefano, Petruzzelli, Stefano, Scuri, Mario, Roche, Nicolas, Singh, Dave

“…Evidence is scarce on the relative risk-benefit of inhaled triple therapy, consisting of inhaled corticosteroid, long-acting muscarinic antagonist, and…”
Get full text

Physical activity is increased by a 12-week semiautomated telecoaching programme in patients with COPD: a multicentre randomised controlled trial by Demeyer, H, Louvaris, Z, Frei, A, Rabinovich, R A, de Jong, C, Gimeno-Santos, E, Loeckx, M, Buttery, S C, Rubio, N, Van der Molen, T, Hopkinson, N S, Vogiatzis, I, Puhan, M A, Garcia-Aymerich, J, Polkey, M I, Troosters, T

“…Reduced physical activity (PA) in patients with COPD is associated with a poor prognosis. Increasing PA is a key therapeutic target, but thus far few…”
Get more information

Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler® ) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial by Kanniess, Frank, Scuri, Mario, Vezzoli, Stefano, Francisco, Catherine, Petruzzelli, Stefano

“…Abstract Background The fixed combination of extrafine beclomethasone dipropionate and formoterol fumarate (BDP/FF) pMDI (Foster® ) is approved for treatment…”
Get full text

The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease by Gimeno-Santos, Elena, Raste, Yogini, Demeyer, Heleen, Louvaris, Zafeiris, de Jong, Corina, Rabinovich, Roberto A, Hopkinson, Nicholas S, Polkey, Michael I, Vogiatzis, Ioannis, Tabberer, Maggie, Dobbels, Fabienne, Ivanoff, Nathalie, de Boer, Willem I, van der Molen, Thys, Kulich, Karoly, Serra, Ignasi, Basagaña, Xavier, Troosters, Thierry, Puhan, Milo A, Karlsson, Niklas, Garcia-Aymerich, Judith

“…No current patient-centred instrument captures all dimensions of physical activity in chronic obstructive pulmonary disease (COPD). Our objective was item…”
Get full text

Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments by Garcia-Aymerich, Judith, Puhan, Milo A, Corriol-Rohou, Solange, de Jong, Corina, Demeyer, Heleen, Dobbels, Fabienne, Erzen, Damijan, Frei, Anja, Gimeno-Santos, Elena, Hopkinson, Nicholas S, Ivanoff, Nathalie, Karlsson, Niklas, Louvaris, Zafeiris, Polkey, Michael I, Rabinovich, Roberto A, Scuri, Mario, Tabberer, Maggie, Vogiatzis, Ioannis, Troosters, Thierry

“…The Daily-PROactive and Clinical visit-PROactive Physical Activity (D-PPAC and C-PPAC) instruments in chronic obstructive pulmonary disease (COPD) combines…”
Get more information

Pharmacokinetics and pharmacodynamics of an extrafine fixed pMDI combination of beclometasone dipropionate/formoterol fumarate in adolescent asthma by Kuna, Piotr, Govoni, Mirco, Lucci, Germano, Scuri, Mario, Acerbi, Daniela, Stelmach, Iwona

“…Aim The aim was to investigate the pharmacokinetics and pharmacodynamics of an extrafine pressurized metered‐dose inhaler (pMDI) fixed combination of…”
Get full text

Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients by Voshaar, Thomas, Spinola, Monica, Linnane, Patrick, Campanini, Alice, Lock, Daniel, Lafratta, Anthony, Scuri, Mario, Ronca, Barbara, Melani, Andrea S

“…Inhaler mishandling is a common issue among patients suffering from asthma and is associated with poor clinical outcomes and greater consumption of health-care…”
Get more information

Both moderate and severe exacerbations accelerate physical activity decline in COPD patients by Demeyer, Heleen, Costilla-Frias, Marcos, Louvaris, Zafeiris, Gimeno-Santos, Elena, Tabberer, Maggie, Rabinovich, Roberto A, de Jong, Corina, Polkey, Michael I, Hopkinson, Nicholas S, Karlsson, Niklas, Serra, Ignasi, Vogiatzis, Ioannis, Troosters, Thierry, Garcia-Aymerich, Judith

“…Physical activity (PA) is a relevant outcome measure in chronic obstructive pulmonary disease (COPD). Low PA is prevalent and drives prognosis [1]…”
Get full text

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting [beta]2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial by Singh, Dave, Papi, Alberto, Corradi, Massimo, Pavlisová, Ilona, Montagna, Isabella, Francisco, Catherine, Cohuet, Géraldine, Vezzoli, Stefano, Scuri, Mario, Vestbo, Jørgen

“…Few data are available for the efficacy of "triple therapy" with two long-acting bronchodilators and an inhaled corticosteroid in chronic obstructive pulmonary…”
Get full text

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting beta 2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial by Singh, Dave, Papi, Alberto, Corradi, Massimo, Pavlisova, Ilona, Montagna, Isabella, Francisco, Catherine, Cohuet, Geraldine, Vezzoli, Stefano, Scuri, Mario, Vestbo, Joergen

“…Background Few data are available for the efficacy of "triple therapy" with two long-acting bronchodilators and an inhaled corticosteroid in chronic…”
Get full text

Acute cardiovascular safety of two formulations of beclometasone dipropionate/formoterol fumarate in COPD patients: A single-dose, randomised, placebo-controlled crossover study by Singh, Dave, Ciurlia, Giorgia, Piccinno, Annalisa, Muraro, Annamaria, Bocchi, Maria, Scuri, Mario

“…Abstract Introduction An extrafine combination of beclometasone dipropionate (BDP) and formoterol fumarate (FF) via a pressurised metered-dose inhaler (pMDI)…”
Get full text

Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide by Singh, Dave, Corradi, Massimo, Spinola, Monica, Papi, Alberto, Usmani, Omar S, Scuri, Mario, Petruzzelli, Stefano, Vestbo, Jørgen

“…The goals of COPD therapy are to prevent and control symptoms, reduce the frequency and severity of exacerbations, and improve exercise tolerance. The triple…”
Get full text

Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma by Crisafulli, Ernesto, Zanini, Andrea, Pisi, Giovanna, Pignatti, Patrizia, Poli, Gianluigi, Scuri, Mario, Chetta, Alfredo

“…Inhaled therapy is often considered the cornerstone of asthma management and international guidelines recommend combination therapy of inhaled corticosteroids…”
Get more information

High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids by Paggiaro, Pierluigi, Corradi, Massimo, Latorre, Manuela, Raptis, Helene, Muraro, Annamaria, Gessner, Christian, Siergiejko, Zenon, Scuri, Mario, Petruzzelli, Stefano

“…A high strength of beclomethasone/formoterol fumarate (BDP/FF) in a pressurised metered dose inhaler (pMDI), which contains extrafine BDP (200 μg/actuation)…”
Get full text

Patterns of Physical Activity Progression in Patients With COPD by Koreny, Maria, Demeyer, Heleen, Benet, Marta, Arbillaga-Etxarri, Ane, Balcells, Eva, Barberan-Garcia, Anael, Gimeno-Santos, Elena, Hopkinson, Nicholas S., De Jong, Corina, Karlsson, Niklas, Louvaris, Zafeiris, Polkey, Michael I., Puhan, Milo A., Rabinovich, Roberto A., Rodríguez-Roisin, Robert, Vall-Casas, Pere, Vogiatzis, Ioannis, Troosters, Thierry, Garcia-Aymerich, Judith, Arbillaga-Etxarri, Ane, Benet, Marta, Delgado, Anna, Garcia-Aymerich, Judith, Gimeno-Santos, Elena, Torrent-Pallicer, Jaume, Vilaró, Jordi, Barberan-Garcia, Anael, Rodriguez-Roisín, Robert, Balcells, Eva, Chiaradía, Diego A Rodríguez, Marín, Alicia, Ortega, Pilar, Celorrio, Nuria, Monteagudo, Mónica, Montellà, Nuria, Muñoz, Laura, Toran, Pere, Simonet, Pere, Jané, Carme, Martín-Cantera, Carlos, Borrell, Eulàlia, Vall-Casas, Pere, Ivanoff, Nathalie, Karlsson, Niklas, Corriol-Rohou, Solange, Jarrod, Ian, Erzen, Damijen, Brindicci, Caterina, Higenbottam, Tim, Scuri, Mario, McBride, Paul, Kamel, Nadia, Tabberer, Margaret, Troosters, Thierry, Dobbels, Fabienne, de Boer, Pim, Kulich, Karoly, Glendenning, Alastair, Rudell, Katja, Wilson, Frederick J., Polkey, Michael I., Hopkinson, Nick S., Vogiatzis, Ioannis, Nikai, Enkeleida, van der Molen, Thys, De Jong, Corina, Rabinovich, Roberto A., MacNee, Bill, Puhan, Milo A., Frei, Anja

“…[Display omitted] Although mean physical activity in COPD patients declines by 400–500steps/day annually, it is unknown whether the natural progression is the…”
Get full text